Table of Content

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. CORONARY GUIDEWIRES ARE THE MAJORLY USED APPLICATION
3.2.2. HYDROPHOBIC COATING IS THE FASTEST GROWING COATED TYPE
3.2.3. HOSPITALS ARE THE HIGHEST REVENUE GENERATING END USERS

4. MARKET DYNAMICS
4.1. MARKET SCOPE & DEFINITION
4.2. MARKET DRIVERS
4.2.1. RISE IN PREVALENCE OF CHRONIC DISEASES
4.2.2. INCREASING DEMAND FOR MI PROCEDURES
4.2.3. AWARENESS AMONG PATIENTS ABOUT TREATMENT OPTIONS
4.2.4. PREVAILING HIGH UNMET MEDICAL NEEDS
4.3. MARKET RESTRAINTS
4.3.1. RISKS ASSOCIATED WITH THE USE OF GUIDEWIRES
4.3.2. UNFAVORABLE PREFERENCE FOR DRUGS
4.3.3. ISSUE IN LOST GUIDEWIRE RETRIEVAL
4.4. MARKET OPPORTUNITIES
4.4.1. TECHNOLOGICAL ADVANCEMENTS
4.4.2. SURGE IN THE ADOPTION OF VASCULAR PROCEDURES
4.5. MARKET CHALLENGES
4.5.1. COMPLEXITIES ASSOCIATED IN THE MANUFACTURING OF VASCULAR GUIDEWIRES
4.5.2. PRICING COUPLED WITH PAUCITY OF PRODUCT DIFFERENTIATION

5. MARKET BY APPLICATION
5.1. CORONARY GUIDEWIRES
5.2. PERIPHERAL GUIDEWIRES
5.3. UROLOGICAL GUIDEWIRES
5.4. NEUROVASCULAR GUIDEWIRES

6. MARKET BY COATING TYPE
6.1. COATED
6.2. NON-COATED

7. MARKET BY END USER
7.1. HOSPITALS
7.2. AMBULATORY SURGICAL CENTERS

8. KEY ANALYTICS
8.1. PORTER’S FIVE FORCES MODEL
8.1.1. THREAT OF NEW ENTRANTS
8.1.2. THREAT OF SUBSTITUTE PRODUCTS
8.1.3. BARGAINING POWER OF BUYER
8.1.4. BARGAINING POWER OF SUPPLIER
8.1.5. INTENSITY OF COMPETITIVE RIVALRY
8.2. VALUE CHAIN ANALYSIS
8.3. REGULATORY FRAMEWORK
8.4. SUPPLY CHAIN ANALYSIS
8.5. OPPORTUNITY MATRIX

9. GEOGRAPHICAL ANALYSIS
9.1. EUROPE
9.1.1. GERMANY
9.1.2. FRANCE
9.1.3. THE UNITED KINGDOM
9.1.4. ITALY
9.1.5. SPAIN
9.1.6. REST OF EUROPE

10. COMPETITIVE LANDSCAPE
10.1. MARKET SHARE ANALYSIS
10.2. COMPANY PROFILES
10.2.1. ABBOTT
10.2.2. B BRAUN MELSUNGEN AG
10.2.3. BECTON DICKINSON AND COMPANY
10.2.4. BIOTRONIK SE & CO. KG
10.2.5. BOSTON SCIENTIFIC CORPORATION
10.2.6. CARDINAL HEALTH INC.
10.2.7. COOK MEDICAL LLC
10.2.8. EDWARD LIFESCIENCES
10.2.9. GALTNEEDLETECH
10.2.10. KONINKLIJKE PHILIPS N.V.
10.2.11. MEDTRONIC
10.2.12. MERIT MEDICAL SYSTEMS
10.2.13. OLYMPUS CORPORATION
10.2.14. TERUMO

List of Tables
TABLE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
TABLE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 EUROPE CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE COATED MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE NON-COATED MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 11 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 14 GERMANY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 GERMANY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 16 GERMANY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 17 FRANCE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 18 FRANCE VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 19 FRANCE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 20 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 21 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 22 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 23 ITALY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 24 ITALY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 25 ITALY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 26 SPAIN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 SPAIN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 28 SPAIN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
List of Figures
FIGURE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 5 EUROPE VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 6 EUROPE VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 7 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
FIGURE 8 EUROPE VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
FIGURE 9 EUROPE VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
FIGURE 10 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 11 EUROPE VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 13 PORTER’S FIVE FORCE MODEL
FIGURE 14 GERMANY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 15 FRANCE GERIATRIC POPULATION 2012 AND 2017 (MILLIONS)
FIGURE 16 FRANCE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 17 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 18 ITALY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 19 SPAIN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 20 REST OF EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)



List of Figures


List of Figures


FIGURE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 2 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY APPLICATION 2018 & 2027 (%)
FIGURE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY CORONARY GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 4 EUROPE VASCULAR GUIDEWIRES MARKET BY PERIPHERAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 5 EUROPE VASCULAR GUIDEWIRES MARKET BY UROLOGICAL GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 6 EUROPE VASCULAR GUIDEWIRES MARKET BY NEUROVASCULAR GUIDEWIRES 2019-2027 ($ MILLION)
FIGURE 7 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY COATING TYPE 2018 & 2027 (%)
FIGURE 8 EUROPE VASCULAR GUIDEWIRES MARKET BY COATED 2019-2027 ($ MILLION)
FIGURE 9 EUROPE VASCULAR GUIDEWIRES MARKET BY NON-COATED 2019-2027 ($ MILLION)
FIGURE 10 EUROPE VASCULAR GUIDEWIRES MARKET SHARE BY END USER 2018 & 2027 (%)
FIGURE 11 EUROPE VASCULAR GUIDEWIRES MARKET BY HOSPITALS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE VASCULAR GUIDEWIRES MARKET BY AMBULATORY SURGICAL CENTERS 2019-2027 ($ MILLION)
FIGURE 13 PORTER’S FIVE FORCE MODEL
FIGURE 14 GERMANY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 15 FRANCE GERIATRIC POPULATION 2012 AND 2017 (MILLIONS)
FIGURE 16 FRANCE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 17 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 18 ITALY VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 19 SPAIN VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
FIGURE 20 REST OF EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)

 

List of Tables


TABLE 1 EUROPE VASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 2 MAJOR COMPLICATIONS CAUSED BY GUIDEWIRES DURING ENDOVASCULAR OR STENTING PROCEDURES
TABLE 3 EUROPE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 4 EUROPE CORONARY GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 5 EUROPE PERIPHERAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 6 EUROPE UROLOGICAL GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 7 EUROPE NEUROVASCULAR GUIDEWIRES MARKET 2019-2027 ($ MILLION)
TABLE 8 EUROPE COATED MARKET 2019-2027 ($ MILLION)
TABLE 9 EUROPE NON-COATED MARKET 2019-2027 ($ MILLION)
TABLE 10 EUROPE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 11 EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)
TABLE 12 EUROPE AMBULATORY SURGICAL CENTERS MARKET 2019-2027 ($ MILLION)
TABLE 13 EUROPE VASCULAR GUIDEWIRES MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 14 GERMANY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 15 GERMANY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 16 GERMANY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 17 FRANCE VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 18 FRANCE VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 19 FRANCE VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 20 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 21 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 22 THE UNITED KINGDOM VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 23 ITALY VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 24 ITALY VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 25 ITALY VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)
TABLE 26 SPAIN VASCULAR GUIDEWIRES MARKET BY APPLICATION 2019-2027 ($ MILLION)
TABLE 27 SPAIN VASCULAR GUIDEWIRES MARKET BY COATING TYPE 2019-2027 ($ MILLION)
TABLE 28 SPAIN VASCULAR GUIDEWIRES MARKET BY END USER 2019-2027 ($ MILLION)